LANCRIX

Shopping Cart(0) | Register

Email Password 

Remember me on this computer  |  Forgot password?

CI994, ≥99%

Catalog No. 737363

General Information
SynonymsAcetyldinaline, Tacedinaline
CAS No.112522-64-2
M.F.

C15H15N3O2

M.W. 269.30
MDL No.MFCD00866266
Technical Data
AppearanceWhite powder
Assay≥99% HPLC
SolubilityDMSO
Storage-20℃
DescriptionCI994 is an oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells. It is used for combination therapy for selected tumors including non-small cell lung, pancreatic, breast, and colorectal cancers. It acts as a histone deacetylase inhibitor.
Safety Data
SymbolGHS07
Hazard StatementsH319
Precautionary StatementsP305 + P351 + P338
Hazard SymbolsXi
Risk StatementsR36
Safety StatementsS26
WGK Germany3
RTECSCU8702023
Reference

Pontiki, E. et al. Med, Res. Rev., 32, 1, (2012)
Gediya, L.K., et al. Bioorg. Med. Chem. 16, 3352-3360, (2008)
Hubeek, I., et al. Oncol. Rep. 19, 1517-1523, (2008)
Pauer, L.R. et al. Cancer Invest., 22, 886, (2004)
Nemunaitis, J.J. et al. Cancer J., 9, 58. (2003)

Size Price Quantity Favorites
10 mg USD50
50 mg USD175
200 mg USD490

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS